Gunilla Savring

Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion harbors the backbone core management, financing resources and business administration together with a network of skilled competences and seek to match that with external sources of innovation from academia or industry. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract industrial partners fitted to drive the late phases of clinical development and commercialization.

Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current approvals to also include treatment with imILT®, the Companys interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal treatment effect. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B.

Cryptzone reduces the enterprise attack surface by 99% with its secure network access solutions. Using a distributed, scalable and highly available Software-Defined Perimeter model, Cryptzone protects applications and content from internal and external threats while significantly lowering costs. In cloud environments including AWS and Azure, Cryptzone provides user access control, increases operational agility and improves the ability to meet regulatory and compliance standards. More than 450 companies rely on Cryptzone to secure their network and data. For more information go to www.cryptzone.com.

Terranet is on a mission to save lives in urban traffic. We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) that improve safety for everyone who moves on the road. With a unique patented vision technology, Terranet’s anti-collision system BlincVision scans and detects road objects ten times faster and with higher accuracy than any other ADAS technology available today. Terranet is based in Lund, Sweden, and in the heart of the European automotive industry in Stuttgart, Germany. The company is listed on Nasdaq First North Premier Growth Market since 2017(Nasdaq: TERRNT-B).

Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion harbors the backbone core management, financing resources and business administration together with a network of skilled competences and seek to match that with external sources of innovation from academia or industry. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract industrial partners fitted to drive the late phases of clinical development and commercialization.

Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current approvals to also include treatment with imILT®, the Companys interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal treatment effect. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B.

Cryptzone reduces the enterprise attack surface by 99% with its secure network access solutions. Using a distributed, scalable and highly available Software-Defined Perimeter model, Cryptzone protects applications and content from internal and external threats while significantly lowering costs. In cloud environments including AWS and Azure, Cryptzone provides user access control, increases operational agility and improves the ability to meet regulatory and compliance standards. More than 450 companies rely on Cryptzone to secure their network and data. For more information go to www.cryptzone.com.

Terranet is on a mission to save lives in urban traffic. We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) that improve safety for everyone who moves on the road. With a unique patented vision technology, Terranet’s anti-collision system BlincVision scans and detects road objects ten times faster and with higher accuracy than any other ADAS technology available today. Terranet is based in Lund, Sweden, and in the heart of the European automotive industry in Stuttgart, Germany. The company is listed on Nasdaq First North Premier Growth Market since 2017(Nasdaq: TERRNT-B).